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Metallothionein isogene transcription in red blood cell precursors
from human cord blood
Mohammad T. Rahman* and Marc De Ley
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The in vitro transcription patterns for 10 functional
metallothionein (MT) isogenes have been investigated in
red blood cell (RBC) precursors from human cord blood.
Active transcription status of the isogenes, MT-0, MT-1A,
MT-1B, MT-1E, MT-1G, MT-1X, and MT-2A, was detected
in both ex vivo expanded RBC precursors (burst-forming
unit-erythroid) and glycophorin A1 and CD711 cells
separated by magnetic cell sorting. Transcription patterns
of these isogenes were analyzed at different times of
incubation with the addition of Zn supplement. In neither
the ex vivo expanded precursors nor glycophorin A1 and
CD711 cells could MT-1F and MT-3 be detected.
Transcripts of MT-4 were detected in glycophorin A1 and
CD711 cells. Erythropoietin-responsive constitutive tran-
scription of MT-1X and possible interleukin-3-responsive
downregulation of MT-2A in ex vivo expanded precursors
reveal their effect on MT biosynthesis. Biosynthesis and
induction of MT at the protein level in the RBC precursors
was also demonstrated by immunoblotting.
Keywords: erythropoietin; glycophorin A; interleukin-3;
metallothionein; zinc status.
The occurrence and biosynthesis of metallothioneins
(MTs), a family of cysteine-rich low-Mr metal-binding
proteins, has been reported in different human tissues,
e.g. liver [1±3], kidney [4], brain [5], and blood cells, e.g.
lymphocytes [6,7], monocytes [8], platelets [9], and
erythrocytes [10]. Since its discovery [11], MT has been
recognized for its physiological importance in detoxifi-
cation of toxic heavy metals, such as cadmium [12],
homeostasis of essential heavy metals, such as Zn [13],
and radical scavenging [14,15]. Its role in cell proliferation
and differentiation has also been recognized in different
cell/tissue types [16±19].
Based on the difference in the charge-separable elution
pattern in HPLC, human MTs were first grouped into two
isoforms, MT-1 and MT-2 [1]. A third charge-separable
fraction of MTs from human fetal liver was reported and
termed MT-0 by Soumillion et al. [20]. Human MT-3
expression was reported to be brain specific [5]. However,
MT-3 mRNA has been reported in human kidney [21],
lymphocytes [7], and the reproductive system [22]. So far,
MT-4 expression has only been reported in stratified
squamous epithelia in both human and mouse [23]. Besides
these five isoforms, subisoform-specific expression of MT
in different human tissues has been reported at both the
protein and mRNA level [3,7,20,24]. Despite the tissue
specificity of some of the members of the MT protein
family, some isoforms such as MT-2A are reported to be
ubiquitous in human tissues. The differential expression
patterns of MT isoforms are attributed to their control
at the molecular level [25]. Inducer-specific differential
expression patterns have also been reported [26,27].
The inability of anucleated RBCs to synthesize protein
has provoked speculation on the origin of MT therein.
Lambert et al. [28] have shown the presence of MT mRNA
in reticulocytes and speculated on its possible role in
differentiation. Several investigators have suggested differ-
ent possibilities. Early bone marrow precursors have been
hypothesized to be the source of MT in murine RBCs
because of the change in MT concentration in murine
erythroid progenitor cells in response to dietary Zn intake
and status [29]. MT originated in organs such as the spleen
has also been suggested to be transferred to RBCs [30]. In
mice, proerythroblasts have been hypothesized as the site of
MT biosynthesis, which are in turn present in mature RBCs
[31]. A study of cadmium-adminstered mice has shown that
the Cd-MT present in mature RBCs is not transferred from
plasma [32]. In a recent review, the induction, regulation,
and biological significance of mammalian MTs have been
described [33].
In our recent report [34], we demonstrated Zn induction
of MTs in human nucleated RBC precursors (nRBCs) from
umbilical cord blood. As an extension of this investigation,
we here report the isoform-specific transcription pattern in
human RBC precursors in the presence and absence of Zn,
a potent MT inducer. In addition, we also investigated the
effect of erythroid growth proliferation/differentiation-
promoting factors such as erythropoietin (EPO) and
interleukin-3 (IL-3) on MT isogene transcription. Con-
firmation of the precursor origin of MTs in RBCs using the
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active MT isogene transcription pattern would be a
significant step in the assessment of Zn status by
erythrocyte Zn-MT content. The functional MT isogene
transcription patterns in the RBC precursors in the presence
or absence of Zn, in combination with EPO and IL-3,
support the possible correlation between RBC differentia-
tion and MT biosynthesis.
M A T E R I A L S A N D M E T H O D S
Separation of RBC precursors
Human cord blood was collected in anticoagulant (acid/
citrate/dextrose solution) and kept at 4 8C for not more
than 12 h before use. Mononuclear cells (MNCs) were
separated from human cord blood by density-gradient
centrifugation on lymphoprepTM (Nycomed AS, Oslo,
Norway) as described by Bùyum [35]. Finally, RBC
precursors were obtained from the MNCs in two ways.
Ex vivo expansion of burst-forming unit erythroid (BFU-E)
colonies in semisolid cell culture medium. Briefly, non-
adherent MNCs were recovered by removing the
plastic adherent cells and washed three times with
NaCl/Pi followed by incubation at a density of
< 5  104 cells´mL21 in methylcellulose semisolid cell
culture medium (MethoCultTM; StemCell Technologies,
Vancouver, BC, Canada) supplemented with EPO
(3 U´mL21) and IL-3 (5 ng´mL21) in 24-well tissue culture
plates; BFU-E colonies were picked up that were grown
in a humidified 5% CO2 incubator at 37 8C; the purity of
these erythroid precursors, hereafter named nRBCs, was
checked by May-GruÈnwald-Giemsa staining (Fig. 1A).
Magnetic cell sorting (MACS) separation of glycophorin
A1 (gly A1) and CD711 cells. Briefly, MNCs separated
from human cord blood were washed in NaCl/Pi containing
2 mm EDTA and 3% (w/v) BSA, and incubated for 15 min
at 6 8C with glycophorin A and CD71 (transferrin receptor)
microbeads; positive-selection columns (LS1/VS1 type)
were used according to the manufacturer's instructions
(reagents and equipment from Miltenyi Biotech, Bergisch
Gladbach, Germany); further enrichment of the positively
selected gly A1 and CD711 cells was achieved by a second
pass of positive selection using fresh reagents and columns.
The morphology of the MACS-separated gly A1 and
CD711 cells was also checked by May-GruÈnwald-Giemsa
staining (Fig. 1B,C).
In vitro Zn induction and extraction of polyadenylated
mRNA
Enriched populations of nRBCs or MACS-separated
gly A1 and CD711 cells were used for in vitro Zn
induction of MT biosynthesis. Zinc induction was carried
out at different concentrations of zinc acetate (as indicated)
in RPMI 1640 supplemented with 10% (v/v) fetal bovine
serum, 0.005% (w/v) gentamicin, 2 mm glutamine (all from
Gibco±BRL, Life Technologies Ltd, Paisley, Scotland,
UK), 1% (w/v) glucose (Sigma, St Louis, MO, USA),
10 mm 2-mercaptoethanol (Fluka, Neu-Ulm, Germany);
similar control cultures were maintained without Zn
supplement. EPO (3 U´mL21) or IL-3 (5 ng´mL21) was
added in parallel control and induced cultures as indicated.
Poly(A)-rich mRNA was extracted from either the
cultured cells at different times as indicated or the freshly
MACS-separated gly A1 and CD711 cells using the
commercially available mRNA extraction kit MICROPO-
LY(A)PURETM (Ambion, Austin, TX, USA) according to
the manufacturer's instructions. To obtain a more concen-
trated solution of mRNA, three different extracted mRNA
pools from similar cultures were combined.
cDNA synthesis and MT-isoform-specific PCR
For the synthesis of cDNA, we used the GeneAmpw RNA
PCR Core kit (PerkinElmer, Roche Molecular System,
Branchburg, NJ, USA); briefly, for a final reaction volume
of 20 mL, 1 mg mRNA and 50 pmol oligo(dT) as a first-
strand cDNA primer were initially heated at 72 8C for
5 min followed by snap cooling on ice; from a single
master mix preparation containing 1  PCR buffer II,
2 mm each dNTP (dATP, dCTP, dTTP, dGTP), 5 mm
MgCl2, 20 U RNase inhibitor, and 50 U murine leukemia
virus reverse transcriptase were added to the oligo(dT)
annealed mRNA; first-strand cDNA synthesis was carried
out at 37 8C for 50 min in a thermocycler (PHC-3; Techne,
Cambridge, UK) followed by the heat inactivation of the
enzyme at 99 8C for 5 min.
Hot start PCR was performed with the cDNA using
published MT-isoform-specific primers [24]. For a final
reaction volume of 50 mL, equal amounts (2 mL) of
Fig. 1. Nucleated RBC precursors from human cord blood.
Photomicrographs after May-GruÈnwald-Giemsa staining of (A) RBC
precursors obtained from BFU-E colonies consisting mainly of
proerythroblasts, (B) MACS-separated gly A1 cells consisting of
orthocromatic/polychromatic erythroblasts and reticulocytes, and
(C) MACS-separated CD711 populations consisting of reticulocytes.
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reverse-transcribed cDNA and 15 pmol of each upstream
and downstream primer for each MT isoform were first
heat denatured at 95 8C for 3 min; from a single master
mix, 2 mm each dNTP, 1  PCR buffer (10 mm Tris/HCl,
pH 9.0, 50 mm KCl, 2.5 mm MgCl2), and 2.5 U Taq
polymerase (Gibco-BRL, Life Technologies) were imme-
diately added to the heat-denatured cDNA; amplification
was carried out for not more than 35 cycles of heat
denaturation at 95 8C for 1 min, primer annealing at 63 8C
(55 8C for MT-1B), and extension at 75 8C for 1 min
followed by one cycle of final extension at 75 8C for 5 min.
Sample variations for either cDNA synthesis of PCR were
minimized using the same master mix from the same batch
of reagents. A negative control (to check for genomic DNA
contamination) was tested for the housekeeping gene
glyceraldehyde-3-phosphate dehydrogenase (G3PDH)
according to the published sequence [36] using the
extracted mRNA from each sample directly in PCR,
hereafter indicated as `±'. To check the progress of the
PCR amplification in exponential phase, primers for
G3PDH were also analyzed by RT-PCR, hereafter indicated
as ` 1'. Constitutive transcription was assumed when retro-
transcripts were found only in control cultures, and
inducible transcription refers to transcription observed
only after Zn treatment. Upregulated transcription was
judged by the increased band intensity of the cDNA pools
from the Zn-induced cultures compared with that from
the control cultures. Comparisons were made only
among amplified retro-transcripts started from the same
amount of mRNA and amplified from the same volume of
cDNA.
Agarose gel electrophoresis
Amplified retro-transcripts were resolved by agarose
(typically 2.2%) gel electrophoresis. Care was taken when
different samples were applied to the gel for comparison
with each other using equal volumes (typically 6 mL) of
PCR products. Gels were photographed under UV light
after ethidium bromide staining.
Extraction of total proteins and detection of MT
Total proteins were extracted by cell lysis in 10 mm Tris/
HCl (pH 7.4) for three cycles of freezing (in a CO2 /ethanol
bath at 272 8C for 5 min) and thawing (at 37 8C in a water
bath for 5 min). Lysed cell suspensions were centrifuged at
14 000 g for 15 min; supernatant was collected in a fresh
microcentrifuge tube and heated in a boiling water bath for
2 min followed by another round of centrifugation at
14 000 r.p.m. for 15 min. Total protein from the final
supernatant was measured by the spectrophotometric
method of Bradford [37]. BSA was used as the reference
for the calibration. Immunoblotting was used to detect MT,
as described by Aoki et al. [38] using equal amounts of
heat-denatured total protein (from control and induced
cultures) after electrophoresis on SDS/PAGE; E9 (Dako,
Carpinteria, CA, USA), mouse anti-MT, was used as the
primary antibody, alkaline phosphatase-conjugated goat
anti-mouse IgG was used as the secondary antibody, and
immune reactivity was observed using 4-nitrophenyl
phosphate (disodium salt; 6H2O; Sigma, Steinheim,
Germany) and 5-bromo-4-chloro-3-indolyl phosphate
(Sigma) as substrate.
R E S U LT S
Transcription of MT isogenes in nRBCs in response to Zn
Transcripts of 10 functional MT isogenes were investigated
by RT-PCR in both the control and Zn-treated cultures.
Constitutive transcription of only MT-2A was observed in
the control cultures at 48 h (Fig. 2A). Inducible transcrip-
tion of MT-1E, MT-1G, and MT-1X was detected 48 h after
treatment with 60 mm Zn (Fig. 2B), and MT-0 (also known
as MT-1H), MT-1A, MT-1B, MT-1E, MT-1G, and MT-1X
were inducibly transcribed in similar cultures treated with
100 mm Zn (Fig. 2C). Continuation of control cultures
until 96 h resulted in constitutive transcription of three
more isogenes, MT-1E, MT-1G, and MT-1X in addition to
MT-2A (Fig. 2D). In the cultures treated with 100 mm Zn,
Fig. 2. Transcription of MT isogenes in
ex vivo expanded nRBCs at different Zn
concentrations. Only MT-2A was
constitutively transcribed at 48 h (A) while
MT-1E, MT-1G, MT-1X, and MT-2A were
constitutively transcribed at 96 h (D).
Inducible or upregulated transcription (as
indicated in the text) of MT-1A, MT-1B,
MT-1E, MT-1G, MT-0, MT-1X, and
MT-2A in culture treated with 100 mm Zn
are observed at both 48 h (C) and 96 h (E).
The absence of any band for MT-1F, MT-3
and MT-4 indicates their transcriptionally
inactive state. (B) Transcripts of MT-1E,
MT-1G, MT-1X, and MT-2A were detected
48 h after treatment with 60 mm Zn. bp,
DNA size marker, 100-bp ladder.
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inducible transcription of MT-1A, MT-1B, and MT-0
and upregulated transcription of MT-1E, MT-1G, MT-1X,
and MT-2A were observed at 96 h (Fig. 2E). Transcripts
of three other functional isoforms, i.e. MT-1F, MT-3, and
MT-4, could not be detected even after in vitro Zn treatment
either at 48 h (Fig. 2B,C) or at 96 h (Fig. 2E), and are
considered to be transcriptionally inactive.
MT isogenes in gly A1 and CD711 cells
The precursor population from the RBC lineage harvested
as MACS-separated gly A1 and CD711 cells were
investigated for the presence of different MT isogene
transcripts. Transcripts of MT-0, MT-1A, MT-1B, MT-1E,
MT-1G, MT-1X, and MT-2A isogenes were detected by
RT-PCR at 0 h (i.e. mRNA was extracted just after the
separation of these cells from the cord blood MNCs) in
both gly A1 (Fig. 3A) and CD711 (Fig. 3B) cell popu-
lations. To our surprise, transcripts of MT-4 were also
detected by RT-PCR in both cell types. However, transcripts
of MT-1F and MT-3 could not be detected. The effect on
the changes in total MT transcripts (regardless of MT
isogenes) 48 h after treatment with 100 mm Zn in both
these cell populations was also investigated by RT-PCR.
Upregulation of total MT transcription was clearly demon-
strated by the increased amplified cDNA pools from
Zn-induced cultures compared with those from control
cultures of both the gly A1 and CD711 cells (Fig. 3C).
Possible order of activation of MT isogenes in response
to Zn
To determine the order of activation of the functional
isogenes, concentration-dependent isogene transcription
patterns were assessed. nRBC cell cultures incubated at
different concentrations of Zn for 48 h were investigated.
At a lower concentration (60 mm), four isogenes, namely
MT-1E, MT-1G, MT-1X, and MT-2A, were found to be
transcribed (Fig. 2B), whereas at a higher concentration
(100 mm) seven isogenes, MT-0, MT-1A, MT-1B, MT-1E,
MT-1G, MT-1X, and MT-2A, were transcribed (Fig. 2C).
Therefore, the seven functional isogenes are possibly
activated in response to Zn in the order: MT-2A . (MT-
G/MT-1X/MT-1E) . (MT-1A/MT-1B/MT-0).
Relative abundance of MT isogenes in response to Zn
To check the relative abundance of the active isogenes,
amplified retro-transcripts were assessed at different cycles
during PCR amplification. To ensure homogeneity and to
minimize sample variation, RT-PCR was carried out using
the same master mixtures. Moreover, cDNA synthesized
using mRNA extracted from three different nRBC cultures
treated with 100 mm Zn for 48 h were combined for
PCR amplification. The comparative abundance of the
different isogenes was determined by the order of
appearance of the respective retro-transcripts amplified
for different numbers of PCR cycles analyzed on agarose
gel. MT-2A was omitted from this experiment as it is
constitutively present, and MT-1F, MT-3, and MT-4 were
also omitted because they were found to be transcrip-
tionally inactive. At the 26th cycle of PCR amplification,
MT-1E, MT-1G, and MT-1X were detected along with a
weaker signal for MT-0 (Fig. 4A). At the 28th cycle,
Fig. 3. Isogene-specific transcription of MT in MACS-separated
gly A1 and CD711 cells. In both the gly A1 (A) and CD711 (B) cell
populations, mRNA for MT-1A, MT-1B, MT-1E, MT-1G, MT-0, MT-
1X, MT-2A, and MT-4 was detected. Zn induction for 48 h also caused
the upregulated transcription of total MT isogenes compared with the
control and induced cultures of both the gly A1 and CD711 cells (C).
bp, DNA size marker, 100-bp ladder.
Fig. 4. Relative abundance of MT isogene transcripts in nRBCs
48 h after treatment with 100 mm Zn. (A) MT-1X, MT-1E, MT-1E,
and MT-0 transcripts were detected in the earliest cycles (26 cycles).
(B) Increased band intensities for MT-1X, MT-1E, MT-1E, and MT-0
transcripts and appearance of MT-1A were observed at 28 cycles. (C)
Further increase in band intensities for MT-1X, MT-1E, MT-1E, MT-0,
and MT-1A transcripts were again observed at 30 cycles. The band
intensity for the housekeeping gene G3PDH (1) was also increased
with the increase in number of PCR cycles; the absence of genomic
DNA contamination was checked using extracted mRNA directly by
PCR for the presence of G3PDH (±). bp, DNA size marker, 100-bp
ladder.
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transcripts for MT-1A appeared along with increased band
intensities for the MT-1E, MT-1G, MT-0, and MT-1X
transcripts (Fig. 4B). A further increase in band intensity
for MT-1A, MT-1E, MT-1G, MT-0, and MT-1X transcripts
was observed after 30 cycles (Fig. 4C). After 30 cycles of
PCR amplification, MT-1B had not yet appeared, although
its active status with Zn treatment was confirmed elsewhere
(Figs 2B, 2D, 3A, 3B). The band intensity of the house-
keeping gene G3PDH also increased with increasing
number of PCR cycles. Therefore, the relative abundance
of the active isogenes in human RBC precursors is in
the order: MT-2A . (MT-1G < MT-1E < MT-1X) .
MT-0 . MT-1A . MT-1B.
Effect of EPO and IL-3 on MT isogene transcription in
nRBCs
The effect of EPO and IL-3 on MT isogene transcription
in nRBCs was shown using RT-PCR. In the EPO-
supplemented control cultures, MT-1X and MT-2A
(Fig. 5A) were constitutively transcribed, and in the IL-3-
supplemented control cultures, only MT-2A (Fig. 5C) was
constitutively transcribed. With the addition of 100 mm Zn,
MT-1E, MT-1G, MT-1X, and MT-2A were found to be
transcribed in cultures containing either EPO or IL-3
(Fig. 5B,D). Unlike in the IL-3-containing cultures and the
control cultures without EPO/IL-3, transcription of MT-1X
in addition to MT-2A was detected in the EPO-containing
cultures. On the other hand, relatively weak transcription of
MT-2A was observed in IL-3-containing Zn-induced
cultures (Fig. 5D) compared with that in IL-3-containing
control cultures (Fig. 5C). A weaker signal for MT-1G was
also observed in IL-3-containing Zn-induced cultures
(Fig. 5D). These observations confirm the effect of
erythroid differentiation and/or proliferation growth
factors such as EPO and IL-3 on specific MT isogene
transcription.
Detection of MT at the protein level by
immunoblotting
Biosynthesis of MT was demonstrated in ex vivo expanded
BFU-E colonies and gly A1 and CD711 cells by
immunoblotting (Fig. 6A,B). The presence of MT on the
blotting paper was detected by indirect immunochemical
staining using monoclonal mouse anti-MT (E9) as the
primary antibody. Purified total MT from human fetal liver
was stained in the parallel lanes (lane 1) as the positive
control. At 72 h after treatment with 100 mm Zn,
upregulation of MT biosynthesis was shown by the
difference in band intensity from Zn-induced and control
cultures of nRBCs (Fig. 6A). The presence of MT in
gly A1 and CD711 cells (Fig. 6B) immediately after
MACS separation was also confirmed even without Zn
induction. MT induction was not attempted in these cell
populations as they were found to be in the later stages of
terminal differentiation.
Fig. 5. Transcription of MT isogenes in
response to EPO and IL-3 in nRBCs at
48 h. Transcription of MT-1X and MT-2A is
observed in the EPO-containing control
culture (A) while only MT-2A is transcribed
in the IL-3-containing control culture (C). In
cultures induced with 100 mm Zn, transcrip-
tion of MT-1E, MT-1G, MT-1X, and MT-2A
is observed with the addition of either EPO
(B) or IL-3 (D). Transcripts for MT-1F, MT-3
and MT-4 (along with MT-1A, MT-1B and
MT-0) could not be detected in any of these
cultures. bp, DNA size marker, 100-bp
ladder. 1 , G3PDH.
Fig. 6. Immunoblotting demonstration of MT in RBC precursors
from human cord blood. Monoclonal mouse anti-MT (E9) was used
as the primary antibody; alkaline phosphatase-conjugated goat anti-
mouse IgG was used for indirect staining of the mouse anti-MT. (A)
Zinc induction of MT in ex vivo expanded BFU-E cell population is
shown by the difference in band intensity of MT from Zn-induced (lane
2) and control cultures (lane 3); Zn induction was carried out at
100 mm Zn for 72 h. (B) Presence of MT in total protein extract from
CD711 (lane 2) and gly A1 (lane 3) cell populations; total protein was
extracted from the respective cell populations immediately after MACS
separation. Lane 1 in both (A) and (B) contains purified total MT from
human fetal liver.
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D I S C U S S I O N
Since the complete disclosure of the human MT gene
family on chromosome 16q13 [39,40], isogene-specific
expression of members of this protein family has received
greater attention. The presence of MTs in human
erythrocytes has been documented elsewhere [10,41]. The
nucleated precursor origin of MTs in murine erythrocytes
has long been hypothesized [31], and we have recently
demonstrated Zn induction of MTs in nRBCs from human
cord blood [34]. Using the RT-PCR developed by
Mididoddi et al. [24], later modified by Vandeghinste
et al. [7], we continued investigating the active MT
isogenes in human nRBCs.
Seven functional isogenes, MT-1A, MT-1B, MT-1E,
MT-1G, MT-0, MT-1X, and MT-2A, are confirmed to be
at least transcriptionally active in human RBC precursors.
This was shown either by in vitro Zn treatment of the
ex vivo expanded RBC precursors or in MACS-separated
gly A1 and CD711 cells without in vitro Zn treatment. It is
important to mention here that a higher percentage of more
mature forms of nucleated precursors was found in the
MACS-separated gly A1 and CD711 cells (Fig. 1B,C) than
in ex vivo expanded precursors (Fig. 1A). Considering
tissue-specific or cell-specific MT isoform expression
stringency as summarized above, the in vitro constitutive
transcription of only MT-2A in nRBCs at 48 h and
switching on of three more isogenes (MT-1E, MT-1G,
and MT-1X) at 96 h suggest the transcriptional activation of
different MT isogenes at different stages of erythroid
differentiation, i.e. more isogenes are expected to be
transcribed in more mature forms of precursors.
The peak MT expression at later stages of differentiation
requires explanation, which could be an in vivo kinetic
coincidence instead of a correlation between differentiation
and MT biosynthesis. However, growing evidence on the
possible involvement of MTs in differentiation in many cell
types and its nuclear localization [19] suggest that it is not a
kinetic coincidence.
Constitutive transcription of MT-1X in addition to
MT-2A after EPO addition, unlike IL-3 addition, and
without addition of either of these growth factors in nRBC
cultures, reveals the effect of these erythroid proliferation
and/or differentiation-promoting factors on MT isogene
tanscription. Therefore, EPO is shown to be a new member
in the growing list of MT inducers. A weaker signal for
MT-1G and MT-2A in IL-3-containing Zn-treated cultures
again indicates the effect of IL-3 on individual MT isogene
transcription.
The functional MT isogenes were analyzed by RT-PCR
(a) to investigate their transcription pattern in nRBCs at
different concentrations of Zn, and (b) to assess their
relative abundance and order of activation in response to
Zn. In our experiments, the housekeeping gene G3PDH was
always included for comparison and to select the number of
cycles for the assessment of PCR products before
amplification reached its plateau. Zinc-induction experi-
ments were conducted at different concentrations of Zn
ranging from 30 mm to 150 mm. Under the latter conditions,
cell viability was reduced obviously because of the toxic
level of Zn. However, no more than the seven mentioned
isogenes were found to be transcribed. Under the former
conditions, i.e. at 30±50 mm Zn, variation in the MT-1E
transcripts was observed, and three other isogenes (MT-2A,
MT-1G, and MT-1X) were found to be transcribed in
all cases. The active MT isogenes in nRBCs from
human cord blood are most likely in the order MT-2A .
(MT-1G<MT-1E<MT-1X) . MT-0 . MT-1A . MT-1B.
However, a more precise and quantitative correlation should
be made using strictly quantitative PCR techniques.
The absence of MT-1F isogene transcription in
nRBCs from human cord blood even after induction with
100 mm Zn at 96 h requires further investigation of tissue/
cell-specific regulation of transcription. Unique differential
expression of MT-1F, three times lower than MT-1G, was
explained in response to Cd by the difference in the distinct
TATA motifs in the promoter region of the two isogenes
[25]. Among the other functional MT isoforms, MT-3 and
MT-4 were also found to be transcriptionally inactive in
nRBCs. Although the active status of the MT-4 isogene
could not be demonstrated in the purest form of RBC
precursors obtained by ex vivo expansion of BFU-E
colonies, the presence of this transcript in gly A1 and
CD711 cells could not be rejected as a false-positive PCR
product. The absence of genomic DNA contamination, the
correct size of the amplified sequence, and the absence so
far of any report of a pseudo-gene for MT-4 means that the
only possible explanation of its origin is other cell type(s)
separated along with the gly A1 and CD711 cells as a
result of non-specific selection during MACS.
Many workers have found it difficult to demonstrate MT
in a single band at the correct Mr position (6000±7000) by
immunoblotting. Polymerization due to oxidation or other
unknown cause has been blamed for the smear-like
appearance of MTs on blots. A special Western-blotting
procedure was therefore designed [38] as described in
Materials and methods. In our experience, with the use of
this protocol, the smear-like appearance on the blots can be
avoided, but getting the bands in the correct Mr position
cannot always be guaranteed. However, the parallel
positions of the purified human MTs and staining with
mAbs confirm the presence of MTs in the nRBCs (Fig. 6A)
and in the MACS-separated glyA1 and CD711 cells
(Fig. 6B). Because of the limited number of nRBCs
harvested by ex vivo expansion of the precursors,
differential expression of MT isoforms at the protein level
was not attempted, but this is currently under investigation
using a recent development in mass spectrometry.
The physiological and immunological significance of
Zn was established as an integral component of this
element in many enzymes, transcription factors and
other proteins [42±44]. Nutritional Zn deficiency was
found to be associated with many clinical symptoms
[45,46]. Therefore, it was of clinical importance to find a
reliable and easily monitored index of overall Zn status.
Several investigators suggested erythrocyte Zn-MT as a
potential index for overall Zn status [10,41,47]. Increases in
erythrocyte Cd-MT content were found to correlate with the
amount of Cd administered to mice [32]. However, to make
the proper correlation between overall Zn status and
respective MT in erythrocytes in a particular clinical/
physiological condition, it is important to know the MT
source in mature RBCs. Therefore, the observation of
MT biosynthesis and upregulation at the protein level with
Zn treatment as demonstrated by immunoblotting would
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provide a significant parameter to consider erythrocyte
Zn-MT as a measure of overall Zn status. It remains to be
resolved whether receptor-mediated transfer of MT can
take place, although at least one report has demonstrated
the MT receptor on astrocytes [48].
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